Search clinical trials for: LP-168

Total 2874 results

Merck Sharp & Dohme LLC

Completed

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

HPV Infections
Merck Sharp & Dohme LLC

Completed

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Cervical Cancer | Genital Warts
National Cancer Institute (NCI)

Active, not recruiting

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PRISMA)

Cervical Carcinoma | Human Papillomavirus Infection

Costa Rica
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Healthy

Australia
University Hospital, Basel, Switzerland

Completed

Acute Dose-dependent Effects of DMT in Healthy Subjects (DMT DR)

Healthy

Switzerland
Gomel State Medical University

Recruiting

Urinary Tract Infections in Cirrhosis

Liver Cirrhosis | Urinary Tract Infections

Belarus
AbbVie

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumors Cancer

United States, France, Japan, Puerto Rico, Spain, Taiwan
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis

Carotid Artery Plaque

Canada
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Rheumatoid Arthritis | Ankylosing Spondylitis

Switzerland
InQpharm Group

Withdrawn

Vasoactive Effects of IQP-AS-118 in Healthy Individuals

Cardiovascular Disease | Blood Flow

Germany
InQpharm Group

Completed

Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol

Blood Pressure | Low Density Lipoprotein Cholesterol Level

Germany
Vanda Pharmaceuticals

Completed

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Non-24-Hour Sleep-Wake Disorder

United States
Instituto Nacional de Ciencias Medicas y Nutricion...
Grupo Medifarma, S. A. de C. V.

Completed

Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy

Diabetic Nephropathy | Albuminuria

Mexico
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism

Type 2 Diabetes Mellitus

United States
Weill Medical College of Cornell University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of Sao Paulo and other collaborators

Active, not recruiting

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

HPV Infection | HIV-1-infection | HPV Positive Oropharyngeal Squamous Cell Carcinoma

Brazil, Mexico, Puerto Rico
Second Affiliated Hospital of Xi'an Jiaotong University
Nanjing Legend Biotech Co.

Not yet recruiting

Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

China
Plus Therapeutics

Recruiting

Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (ReSPECT-LM)

Leptomeningeal Metastasis

United States
Antiva Biosciences

Terminated

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

HIV Infection | Anal Cancer | Human Papilloma Virus Infection | HSIL, High-Grade Squamous Intraepithelial Lesions | Anus Neoplasm

United States, Australia
Kineta Inc.

Completed

A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis

Plaque Psoriasis

Canada
Amgen

Completed

Treatment for Patients With Osteoarthritis (OA)

Osteoarthritis
Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (ESRA)

Systemic Sclerosis | Pulmonary Vascular Disorder | Primary Pulmonary Hypertension | Other Systemic Involvement of Connective Tissue

Austria, Germany, Italy, France, Switzerland
Hospital de Clinicas de Porto Alegre
Ministry of Health, Brazil; TelessaúdeRS / UFRGS; State Secretary of Health of...

Active, not recruiting

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Chronic Hepatitis C

Brazil
Biocad

Completed

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis (AURORA)

Seropositive RA

Russian Federation, Belarus
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Psoriasis

United States
University of Tennessee

Completed

Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia (MiBPD)

Bronchopulmonary Dysplasia

United States
Therapeutics, Inc.

Completed

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Plaque Psoriasis

United States
NYU Langone Health

Completed

Oral Microbiome and Pancreatic Cancer

Pancreatic Cancer

United States
University of Kansas Medical Center

Recruiting

Impact of E-cigarette Nicotine Concentration on Compensation

Smoking Cessation

United States
University of Alabama at Birmingham
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Completed

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

Cancer Survivor | Prevention of Human Papillomavirus Infection

United States
Amgen

Completed

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

Osteoporosis
University of Stellenbosch
Nestlè Nutrition Institute Africa; National Research Foundation (NRF) (RSA)

Completed

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

Irritable Bowel Syndrome

South Africa
Vejle Hospital

Active, not recruiting

Shared Decision Making With Anal Cancer Patients on Radiation Dose (PC-Anal-01)

Anal Cancer

Denmark
Genencell Co. Ltd.

Recruiting

Efficacy and Safety of ES16001 in Patients With COVID-19

COVID-19

Korea, Republic of
Seoul National University Hospital
Seoul National University Bundang Hospital

Completed

Plasmalyte-148 Solution and Blood Coagulation

Blood Coagulation Disorder

Korea, Republic of
University of Toronto
Diabetes Canada; Wharton Medical Clinic

Not yet recruiting

Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

Hyperglycemia | Obesity | Diabetes Mellitus, Type 2 | Prediabetic State

Canada
Merck Sharp & Dohme LLC

Completed

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Papillomavirus Infections
Laboratorios Sophia S.A de C.V.

Withdrawn

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis (PRO-118)

Conjunctivitis, Allergic | Seasonal Allergic Conjunctivitis | Ocular Itching | Ocular Allergy | Perennial Allergic Conjunctivitis

Mexico
Saisei Pharma

Completed

Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients (SaiseiCovUKR)

Covid19

Ukraine
Therapeutics, Inc.

Completed

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (305)

Plaque Psoriasis

United States
Radboud University Medical Center
Terumo Medical Corporation; Quirem Medical B.V.

Recruiting

Percutaneous Holmium Injection in Pancreatic Cancer (SLOTH-2a)

Pancreas Cancer

Netherlands
Phrixus Pharmaceuticals, Inc.
Charley's Fund

Terminated

Safety and Efficacy of P-188 NF in DMD Patients

Duchenne Muscular Dystrophy

United States
Molecular NeuroImaging

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects

Healthy Volunteers

United States
GlaxoSmithKline

Completed

Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy

Muscular Dystrophies

Germany, Belgium, Turkey, Netherlands, Spain, Israel, Australia, France, United Kingdom
Vanda Pharmaceuticals

Completed

Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects

Healthy Volunteers

United States
Plus Therapeutics

Not yet recruiting

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Glioma
Plus Therapeutics
National Cancer Institute (NCI)

Recruiting

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Glioma

United States
Hallym University Kangnam Sacred Heart Hospital

Completed

Nutritional Intake and Gut Microbiome

Obesity, Childhood

Korea, Republic of
AbGenomics B.V Taiwan Branch

Completed

A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

Psoriatic Arthritis

United States
National Cancer Institute (NCI)

Active, not recruiting

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7

United States
Charleston Laboratories, Inc

Completed

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Pain | Nausea | Vomiting

Search clinical trials for: LP-168

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations